Claim Details

View detailed information about this claim and its related sources.

Back to Claims

Claim Information

Complete details about this extracted claim.

Claim Text
The industry was working on a number of issues advancing in Congress — including reforming the 340B discount drug program, alleviating supply chain issues and reining in pharmacy benefit managers, which negotiate discounts on drugs and choose which medicines insurance plans will cover.
Simplified Text
The industry was working on issues advancing in Congress
Confidence Score
0.900
Claim Maker
The author
Context Type
News Article
Context Details
{
    "date": "04\/24\/2024",
    "topic": "Pharma lobbying",
    "source": "POLITICO"
}
UUID
a1165f69-4450-49be-bea2-2082dcde99d0
Vector Index
✗ No vector
Created
February 15, 2026 at 4:57 PM (6 months ago)
Last Updated
February 15, 2026 at 4:57 PM (6 months ago)

Original Sources for this Claim (1)

All source submissions that originally contained this claim.

Screenshot of https://www.politico.com/newsletters/politico-pulse/2024/04/24/pharma-lobbying-up-in-2024-00153996
Pharma lobbying up in 2024
Completed News
21 claims 🔥
1 week ago
https://www.politico.com/newsletters/politico-pulse/2024/04/24/pharma-lobbying-up-in-2024-00153996

Pharmaceutical companies increased lobbying spending in the first quarter of 2024. Key issues driving the spending include 340B program reform, supply chain issues, and pharmacy benefit manager regulations. The article also covers Supreme Court arguments on abortion and bird flu fragments in milk.

Pharmaceuticals Lobbying Healthcare Policy Abortion Bird Flu Medicare Supreme Court

Similar Claims (5)

Other claims identified as semantically similar to this one.